AU2003262375A8 - Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts - Google Patents

Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts

Info

Publication number
AU2003262375A8
AU2003262375A8 AU2003262375A AU2003262375A AU2003262375A8 AU 2003262375 A8 AU2003262375 A8 AU 2003262375A8 AU 2003262375 A AU2003262375 A AU 2003262375A AU 2003262375 A AU2003262375 A AU 2003262375A AU 2003262375 A8 AU2003262375 A8 AU 2003262375A8
Authority
AU
Australia
Prior art keywords
sulphinyl
benzimidazole
salts
optically active
active substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003262375A
Other versions
AU2003262375A1 (en
Inventor
Vijaykumar Muljibhai Patel
Rohit Ravikant Soni
Rajamannar Thennati
Rajeev Budhdev Rehani
Vijay Chhangamal Chhabada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Ltd
Original Assignee
Sun Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Ltd filed Critical Sun Pharmaceutical Industries Ltd
Publication of AU2003262375A1 publication Critical patent/AU2003262375A1/en
Publication of AU2003262375A8 publication Critical patent/AU2003262375A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
AU2003262375A 2002-04-22 2003-04-21 Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts Abandoned AU2003262375A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN365/MUM/2002 2002-04-22
IN299MU2002 2002-04-22
IN299/MUM/2002 2002-04-22
IN365MU2002 2002-04-22
PCT/IN2003/000164 WO2003089408A2 (en) 2002-04-22 2003-04-21 Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts

Publications (2)

Publication Number Publication Date
AU2003262375A1 AU2003262375A1 (en) 2003-11-03
AU2003262375A8 true AU2003262375A8 (en) 2003-11-03

Family

ID=29252558

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003262375A Abandoned AU2003262375A1 (en) 2002-04-22 2003-04-21 Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts

Country Status (2)

Country Link
AU (1) AU2003262375A1 (en)
WO (1) WO2003089408A2 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004046134A2 (en) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
US7507829B2 (en) 2002-12-19 2009-03-24 Teva Pharmaceuticals Industries, Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
US20060281782A1 (en) * 2003-03-28 2006-12-14 Avraham Cohen Method for the enantioselective preparation of sulphoxide derivatives
FR2852956B1 (en) * 2003-03-28 2006-08-04 Negma Gild PROCESS FOR THE ENANTIOSELECTIVE PREPARATION OF SULFOXIDE DERIVATIVES
FR2863611B1 (en) * 2003-12-15 2006-03-24 Sidem Pharma Sa PROCESS FOR THE ENANTIOSELECTIVE PREPARATION OF SULFOXIDE DERIVATIVES
US20070060556A1 (en) 2003-05-05 2007-03-15 Yatendra Kumar Barium salt of benzimidazole derivative
SE0400410D0 (en) 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
CN1972928A (en) 2004-06-24 2007-05-30 阿斯利康(瑞典)有限公司 New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
ES2246149B1 (en) 2004-07-02 2007-06-01 Esteve Quimica, S.A. SOLID FORMS OF S-OMEPRAZOL MAGNETIC SALT AND PROCEDURES FOR PREPARATION.
FR2876101B1 (en) * 2004-10-05 2007-03-02 Sidem Pharma Sa Sa PROCESS FOR THE ENANTIOSELECTIVE PREPARATION OF SULFOXIDE DERIVATIVES
SI1802584T1 (en) 2004-10-11 2010-01-29 Ranbaxy Lab Ltd Processes for the preparation of substituted sulfoxides
JP4837722B2 (en) * 2005-03-25 2011-12-14 リブゾン ファーマシューティカル グループ インク． Substituted sulfoxide compounds, methods for their preparation, and methods for their use
DE102005061720B3 (en) * 2005-12-22 2006-10-19 Ratiopharm Gmbh Preparing optically active omeprazole enantiomers, useful to treat stomach diseases, comprises oxidizing prochiral sulfide compound with oxidizing agent in presence of titanium complex catalyst and reacting the catalyst with chiral diols
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US8063074B2 (en) 2006-05-04 2011-11-22 Dr. Reddy's Laboratories Limited Polymorphic forms of esomeprazole sodium
US7786309B2 (en) 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
EP2000468A1 (en) 2007-05-09 2008-12-10 Dr. Reddy's Laboratories Ltd. Esomeprazole salts and processes for preparation thereof
US8106210B2 (en) * 2007-10-08 2012-01-31 Hetero Drugs Limited Polymorphs of esomeprazole salts
EP2143722A1 (en) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
EP2264024A1 (en) 2008-10-14 2010-12-22 LEK Pharmaceuticals d.d. Process for the preparation of enantiomerically enriched proton pump inhibitors
JP5714031B2 (en) * 2010-02-12 2015-05-07 エステヴェ キミカ， エス．エー． Preparation method of sodium salt of esomeprazole sodium
CN104887673B (en) * 2011-06-07 2017-12-29 成都国为生物医药有限公司 A kind of pharmaceutical composition containing Esomeprazole sodium and preparation method thereof
CN102850323A (en) * 2011-06-30 2013-01-02 秦引林 Refining method of esomeprazole sodium
CN102351847B (en) * 2011-09-21 2013-01-23 南京优科制药有限公司 Industrial method for refining esomeprazole sodium salt
CN102408412A (en) * 2011-10-25 2012-04-11 广东华南药业集团有限公司 (S)-omeprazole preparation method with high antipode selectivity
CN103420979B (en) * 2012-05-17 2016-04-20 广州莱泰制药有限公司 The process for purification of Esomeprazole sodium
US10307748B2 (en) 2014-12-26 2019-06-04 The University Of Tokyo Method for producing proton pump inhibitor compound having optical activity
CN105566298A (en) * 2016-02-16 2016-05-11 顾伟 Method for preparing esomeprazole sodium
CN107056752A (en) * 2017-04-01 2017-08-18 上海华源医药科技发展有限公司 A kind of preparation method of esomeprazole potassium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504459C2 (en) * 1994-07-15 1997-02-17 Astra Ab Process for the preparation of substituted sulfoxides
SE510650C2 (en) * 1997-05-30 1999-06-14 Astra Ab New association
AU2001252595A1 (en) * 2000-04-28 2001-11-12 Takeda Chemical Industries Ltd. Process for producing optically active sulfoxide derivative

Also Published As

Publication number Publication date
AU2003262375A1 (en) 2003-11-03
WO2003089408A2 (en) 2003-10-30
WO2003089408A3 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
AU2003262375A8 (en) Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
AU2003238179A8 (en) Herbicidally active heterocyclylalkynes
SI1556029T1 (en) Thiomolybdate salts and uses thereof
GB0222210D0 (en) Order management
AU2003287406A8 (en) Digital-rights management
GB0220214D0 (en) Compounds and their use
AU2003226910A8 (en) Laser system
EP1517413A4 (en) Fiber laser unit
AU2003239518A8 (en) Electrochromic salts, solutions, and devices
TW592312U (en) Animal eyewear
AU2003295557A8 (en) Multiple-disks laser system
PL373794A1 (en) New salts
AU155835S (en) Earplug
GB0222962D0 (en) Laser system
AU2003296091A8 (en) Optically active dihydropyridine derivative
EP1528070A4 (en) Optically active high-molecular compounds
AU2003233092A1 (en) Improved electro-optically active device
EP1552803A4 (en) Diaper
GB0201753D0 (en) Laser diodes
GB2415058B (en) Laser level
AU152770S (en) Laser level
AU2003233232A1 (en) Anti-rhinovirus active agents
AU2002302844A1 (en) Improvements in timer management
GB0218031D0 (en) Compounds and their use
GB0204683D0 (en) Pharmaceutical salts

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase